KR100673594B1 - Extracts of soy hypocotyl and/or hull with inhibitory effects on carcinogenesis and composition comprising the same - Google Patents
Extracts of soy hypocotyl and/or hull with inhibitory effects on carcinogenesis and composition comprising the same Download PDFInfo
- Publication number
- KR100673594B1 KR100673594B1 KR1020040099664A KR20040099664A KR100673594B1 KR 100673594 B1 KR100673594 B1 KR 100673594B1 KR 1020040099664 A KR1020040099664 A KR 1020040099664A KR 20040099664 A KR20040099664 A KR 20040099664A KR 100673594 B1 KR100673594 B1 KR 100673594B1
- Authority
- KR
- South Korea
- Prior art keywords
- cancer
- soybean
- composition
- inhibiting
- extract
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 59
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 53
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 208000005623 Carcinogenesis Diseases 0.000 title description 5
- 230000036952 cancer formation Effects 0.000 title description 5
- 231100000504 carcinogenesis Toxicity 0.000 title description 5
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 102
- 244000068988 Glycine max Species 0.000 claims abstract description 99
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 48
- 201000011510 cancer Diseases 0.000 claims abstract description 47
- 239000002904 solvent Substances 0.000 claims abstract description 35
- 230000009702 cancer cell proliferation Effects 0.000 claims abstract description 21
- 208000005718 Stomach Neoplasms Diseases 0.000 claims abstract description 15
- 206010017758 gastric cancer Diseases 0.000 claims abstract description 15
- 201000007270 liver cancer Diseases 0.000 claims abstract description 15
- 208000014018 liver neoplasm Diseases 0.000 claims abstract description 15
- 201000011549 stomach cancer Diseases 0.000 claims abstract description 15
- 206010006187 Breast cancer Diseases 0.000 claims abstract description 13
- 208000026310 Breast neoplasm Diseases 0.000 claims abstract description 13
- 239000007787 solid Substances 0.000 claims abstract description 13
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 235000013376 functional food Nutrition 0.000 claims abstract description 4
- 235000013373 food additive Nutrition 0.000 claims abstract description 3
- 239000002778 food additive Substances 0.000 claims abstract description 3
- 235000021067 refined food Nutrition 0.000 claims abstract description 3
- 210000002257 embryonic structure Anatomy 0.000 claims description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- 235000013361 beverage Nutrition 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 235000020510 functional beverage Nutrition 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims 1
- 230000001093 anti-cancer Effects 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 17
- 210000001161 mammalian embryo Anatomy 0.000 abstract description 15
- 238000000746 purification Methods 0.000 abstract description 6
- 230000005764 inhibitory process Effects 0.000 abstract description 4
- 238000004064 recycling Methods 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 34
- 230000035755 proliferation Effects 0.000 description 23
- 230000000694 effects Effects 0.000 description 12
- 239000000469 ethanolic extract Substances 0.000 description 8
- 235000020712 soy bean extract Nutrition 0.000 description 6
- 230000000711 cancerogenic effect Effects 0.000 description 5
- 239000010903 husk Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 231100000315 carcinogenic Toxicity 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- -1 xyitol Chemical compound 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- FTZIQBGFCYJWKA-UHFFFAOYSA-N 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Chemical compound S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 FTZIQBGFCYJWKA-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000964486 Egle Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000235 effect on cancer Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002700 inhibitory effect on cancer Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000020094 liqueur Nutrition 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 230000035407 negative regulation of cell proliferation Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021057 semi-liquid food Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 암 세포의 증식 억제 효능을 가지고 있는 대두 배아 및/또는 대두 껍질 추출물 및 이를 유효성분으로 포함하는 암 억제용 조성물에 관한 것으로, 상기 대두의 용매추출물은 별도의 정제 과정 없이 안전하게 섭취할 수 있고, 암을 효과적으로 억제할 수 있어 발암 억제용 조성물, 가공식품, 기능성식품, 식품첨가제 등에 유용하게 이용할 수 있고, 동시에 대두껍질을 재활용함으로써 경제성을 향상시킬 수 있다.The present invention relates to a soybean embryo and / or soybean bark extract having cancer cell proliferation inhibitory effect and a composition for inhibiting cancer comprising the same as an active ingredient, wherein the solvent extract of soybean can be safely ingested without a separate purification process. In addition, cancer can be effectively suppressed, and it can be usefully used for a composition for inhibiting cancer, processed food, functional food, food additives, etc., and at the same time, economic efficiency can be improved by recycling soybean hulls.
대두 배아, 대두 껍질, 간암, 위암, 유방암, 고형암, 암 세포 증식 저해, 식품Soybean embryo, soybean hull, liver cancer, stomach cancer, breast cancer, solid cancer, cancer cell proliferation inhibition, food
Description
도 1은 본 발명에 따른 대두 배아 및 대두 껍질의 에탄올 추출물이 간암 세포의 증식을 저해하는 효능을 측정한 그래프이다.1 is a graph measuring the efficacy of ethanol extracts of soybean embryos and soybean hulls according to the present invention inhibit the proliferation of liver cancer cells.
도 2는 본 발명에 따른 대두 배아 및 대두 껍질의 열수 추출물이 간암 세포의 증식을 저해하는 효능을 측정한 그래프이다. Figure 2 is a graph measuring the efficacy of inhibiting the proliferation of liver cancer cells hot water extract of soybean embryos and soybean hulls according to the present invention.
도 3는 본 발명에 따른 대두 배아 및 대두 껍질의 에탄올 추출물이 유방암 세포의 증식을 저해하는 효능을 측정한 그래프이다.Figure 3 is a graph measuring the efficacy of ethanol extracts of soybean embryos and soybean hulls according to the present invention inhibit the proliferation of breast cancer cells.
도 4는 본 발명에 따른 대두 배아 및 대두 껍질의 열수 추출물이 유방암 세포의 증식을 저해하는 효능을 측정한 그래프이다. Figure 4 is a graph measuring the efficacy of inhibiting the proliferation of breast cancer cells hot water extract of soybean embryos and soybean hulls according to the present invention.
도 5는 본 발명에 따른 대두 배아 및 대두 껍질의 에탄올 추출물이 위암 세포의 증식을 저해하는 효능을 측정한 그래프이다.5 is a graph measuring the efficacy of inhibiting the proliferation of gastric cancer cells ethanol extract of soybean embryo and soybean peel according to the present invention.
도 6은 본 발명에 따른 대두 배아 및 대두 껍질의 열수 추출물이 위암 세포의 증식을 저해하는 효능을 측정한 그래프이다. Figure 6 is a graph measuring the efficacy of inhibiting the proliferation of gastric cancer cells hot water extract of soybean embryos and soybean shell according to the present invention.
도 7은 본 발명에 따른 대두 배아 및 대두 껍질의 에탄올 추출물이 고형암 세포의 증식을 저해하는 효능을 측정한 그래프이다.7 is a graph measuring the efficacy of ethanol extracts of soybean embryos and soybean hulls according to the present invention inhibit the proliferation of solid cancer cells.
도 8은 본 발명에 따른 대두 배아 및 대두 껍질의 열수 추출물이 고형암 세포의 증식을 저해하는 효능을 측정한 그래프이다.Figure 8 is a graph measuring the efficacy of the hot water extract of soybean embryos and soybean hulls according to the present invention inhibit the proliferation of solid cancer cells.
본 발명은 여러 암 세포의 증식을 저해하는 효능을 갖는 대두 배아 및/또는 대두 껍질의 용매 추출물과, 이를 유효성분으로 포함하는 발암 억제용 조성물에 관한 것이다. The present invention relates to a solvent extract of soybean embryos and / or soybean hulls having an effect of inhibiting the proliferation of various cancer cells, and a composition for inhibiting carcinogenesis comprising the same as an active ingredient.
수십 년 동안 수술, 방사선요법, 그리고 화학요법에 의한 치료가 이루어져 왔지만, 실질적으로 간암, 유방암, 위암을 포함한 대부분의 상피세포 암들의 발생률 및 이들에 의한 사망률은 줄어들지 않았다[Sporn, M. B., Lancet, 347:1377-1381, 1996]. 이러한 이유는 지난 30년 동안 암을 예방적인 접근보다 치료적인 접근에 의해 연구해왔기 때문이다. 따라서, 이미 밝혀진대로 수십년 동안 지속되는 암의 다단계적 발생을 효과적으로 저해하거나 늦출 수 있는 성분이나 식품을 섭취하는 것은 암의 발생 및 사망률을 낮추는데 보다 실질적인 결과를 가져올 수 있으며, 최근 이에 대한 많은 연구가 진행되고 있다[강진석 외, 화학적 암예방, 고려의학, 2000; Surh, Mutat. Res., 428:305-327, 1998; Sporn, M. B., Lancet, 347:1377-1381, 1996].Although surgery, radiotherapy, and chemotherapy have been used for decades, the incidence and mortality of most epithelial cancers, including liver cancer, breast cancer, and gastric cancer, has not decreased substantially [Sporn, MB, Lancet, 347]. : 1377-1381, 1996. This is because, over the past 30 years, cancer has been studied by a therapeutic approach rather than a preventive approach. Thus, as already known, eating ingredients or foods that can effectively inhibit or slow the multi-stage outbreak of cancer that lasts for decades can have more substantial results in lowering cancer incidence and mortality. [Kang Jin-suk et al., Chemical Cancer Prevention, Korea Medicine, 2000; Surh, Mutat. Res., 428: 305-327, 1998; Sporn, M. B., Lancet, 347: 1377-1381, 1996].
암세포 또는 변형세포는 정상세포보다 훨씬 빠르고 무한정 증식하는 특성을 갖기 때문에 암세포의 증식 억제 효능은 암의 예방 및 억제 효과를 갖는 것으로 인 정되고 있다[강진석 외, 화학적 암예방, 고려의학, 135-136, 2000; Yamasaki, H. et al, Carcinogenesis 11:1051-1058, 1999; Kelloff. G. J. et al., Eur. J. Cancer, 35:1755-1762, 1999; Surh, Y. J., Mutat. Res, 428:305-327, 1999; Trosko, J. E., Cancer Res. 53, 3475-3485 (1993)].Since cancer cells or transformed cells have a much faster and infinitely proliferative characteristic than normal cells, the proliferation inhibitory effect of cancer cells has been recognized to have the effect of preventing and inhibiting cancer [Kang, Jin-seok et al., Chemical cancer prevention, Korea Medicine, 135-136 , 2000; Yamasaki, H. et al, Carcinogenesis 11: 1051-1058, 1999; Kelloff. G. J. et al., Eur. J. Cancer, 35: 1755-1762, 1999; Surh, Y. J., Mutat. Res, 428: 305-327, 1999; Trosko, J. E., Cancer Res. 53, 3475-3485 (1993).
한편, 우리나라의 전통 식품 중 하나인 대두는 식생활에서 중요한 부분을 차지하고 있다. 대두는 일반적으로 양질의 단백질과 지질의 급원으로 사용되기도 하고 된장, 간장 등의 발효식품 및 두부, 콩나물, 콩가루 등의 비발효 식품까지 그 용도가 다양하게 사용되어 온 식품재료이다. 이러한 콩류가 최근에 암을 비롯한 성인병을 예방할 수 있는 기능성 식품으로 각광 받기 시작하였다.On the other hand, soybeans, one of the traditional foods in our country, play an important part in our diet. Soybean is generally used as a source of high-quality protein and lipids, and has been used for various purposes from fermented foods such as miso and soy sauce, and non-fermented foods such as tofu, bean sprouts, and soy flour. These legumes have recently been in the spotlight as functional foods that can prevent cancer and other adult diseases.
그런데, 상기 대두의 부산물로 나오는 대두껍질 및 배아는 거의 대부분 폐기되고 있는 실정이다. 미국대두협회의 자료에 따르면, 2003년 국내에 약 150만톤의 대두가 수입되어 활용되었으며, 이를 통하여 약 4만 5천톤에 이르는 대두껍질과 대두 배아가 폐기되는 부산물로 발생한 것으로 추산되고 있다.By the way, soybean hulls and embryos that are produced as a by-product of the soybean are almost discarded. According to the US Soybean Association data, about 1.5 million tons of soybeans were imported and used in 2003, resulting in about 45,000 tons of soybean hulls and soybean embryos being discarded by-products.
상기 대두를 포함하는 콩의 생리활성과 관련하여, 콩껍질의 콜레스테롤 저해 효과(고미경ㅇ김정인ㅇ문정원ㅇ송영선, 한국콩연구회지, 제15권1호, 23, 1998), 유색콩 껍질의 항산화 효과, 대두 배아의 항동맥경화 효과(강갑석 외, 식품과 건강문화, 광문각, 2001) 등이 일부 연구보고된 바 있다. 그러나, 식품으로 이용되는 대두의 껍질 및 배아 추출물들이 대두나 반할두보다 암세포 증식에 탁월한 효과가 있다는 보고는 전혀 없었다.Cholesterol Inhibitory Effect of Soybean Shell (Kim, Mi-Kin and Moon-Won Song, Young-Song Song, Korean Society of Soybean Research, Vol. 15, No. 1, 23, 1998) Effects and anti-arteriosclerosis effects of soybean embryos (Kang et al., Food and Health Culture, Gwangmungak, 2001) have been reported. However, there have been no reports that the skin and embryo extracts of soybeans used as foods have an excellent effect on cancer cell proliferation than soybeans or halves.
따라서, 버려지고 있는 대두 껍질 및 배아 등에서 유효성분을 추출함으로써 별도의 정제 과정 없이 안전하게 섭취 가능한 암 세포 증식 억제제, 및 이를 포함하는 식품 또는 약제 등을 제공할 필요가 있다.Therefore, there is a need to provide a cancer cell proliferation inhibitor, and a food or drug containing the same, which can be safely ingested without a separate purification process by extracting active ingredients from discarded soybean hulls and embryos.
상기와 같은 문제점을 해결하고자, 본 발명자들은 인체 안전성이 확보된 천연 식품 유래의 발암 억제제를 검색하던 중, 대두 배아 및 대두 껍질 추출물이 간암, 유방암, 위암, 고형암 세포의 증식을 억제하는 효능을 나타내며, 발암 억제 효능을 갖는 것임을 발견함으로써 본 발명을 완성하게 되었다.In order to solve the above problems, the inventors of the present invention, while searching for carcinogenic inhibitors derived from natural foods that ensure human safety, soybean embryos and soybean bark extract exhibits the effect of inhibiting the proliferation of liver cancer, breast cancer, stomach cancer, solid cancer cells The present invention has been completed by discovering that the carcinogenic effect is suppressed.
따라서, 본 발명의 목적은 암 세포 증식 억제 효능을 갖는 대두 배아, 대두 껍질 및 이들의 혼합물로 이루어진 군으로부터 선택된 물질의 용매 추출물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a solvent extract of a substance selected from the group consisting of soybean embryos, soybean hulls and mixtures thereof which have cancer cell proliferation inhibitory efficacy.
본 발명의 다른 목적은 상기 암 세포 증식 억제 효능을 갖는 대두 배아, 대두 껍질 및 이들의 혼합물로 이루어진 군으로부터 선택된 물질의 용매 추출물을 유효성분으로 포함하는 발암 억제용 조성물을 제공하는 것이다.Another object of the present invention is to provide a composition for inhibiting carcinogenesis comprising a solvent extract of a substance selected from the group consisting of soybean embryos, soybean hulls and mixtures thereof having the cancer cell proliferation inhibitory effect as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 암 세포 증식의 억제 효능을 가지는, 대두 배아, 대두 껍질, 및 이들의 혼합물로 이루어진 군에서 선택된 물질의 용매 추출물을 제공한다.In order to achieve the above object, the present invention provides a solvent extract of a substance selected from the group consisting of soybean embryos, soybean hulls, and mixtures thereof, having an inhibitory effect on cancer cell proliferation.
또한, 본 발명은 암 세포 증식 억제 효능을 갖는, 대두 배아, 대두 껍질, 및 이들의 혼합물로 이루어진 군에서 선택된 물질의 용매 추출물을 유효성분으로 포함하는 암 억제용 조성물을 제공한다.In addition, the present invention provides a composition for inhibiting cancer, comprising a solvent extract of a substance selected from the group consisting of soybean embryos, soybean hulls, and mixtures thereof, having an effect of inhibiting cancer cell proliferation.
이하에서 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 대두 배아, 대두 껍질, 이들의 혼합물로 이루어진 군으로부터 선택되는 물질의 용매 추출물과, 이를 유효성분으로 포함하는 암 세포 증식 억제용 조성물에 관한 것이다.The present invention relates to a solvent extract of a substance selected from the group consisting of soybean embryos, soybean hulls, and mixtures thereof, and a composition for inhibiting cancer cell proliferation comprising the same as an active ingredient.
본 발명의 대두 배아, 대두 껍질, 이들의 혼합물로 이루어진 군으로부터 선택된 물질의 용매 추출물은 간암, 유방암, 위암, 또는 고형암 등의 세포의 증식을 억제하는 효능을 나타냄으로써, 발암 억제 효능을 가지며, 별도의 정제 과정 없이 안전하게 섭취 가능하다. 또한, 본 발명은 버려지고 있는 대두 껍질 및 배아 등을 재활용함으로써, 경제적인 효과를 제공할 수 있다.The solvent extract of a substance selected from the group consisting of soybean embryos, soybean hulls, and mixtures thereof of the present invention exhibits the effect of inhibiting the proliferation of cells such as liver cancer, breast cancer, gastric cancer, or solid cancer, and thus has a carcinogenic effect. It can be safely consumed without purification. In addition, the present invention can provide an economic effect by recycling the discarded soybean hulls, embryos and the like.
상기 용매 추출물은, 물 추출물 또는 알콜 추출물로서, 본 기술 분야의 전문가에게 잘 알져진 통상의 추출법을 이용하여 제조할 수 있다. 상기 용매 추출물의 제조방법의 일례로는, 대두 배아, 대두 껍질 및 이들의 혼합물로 이루어진 군으로부터 선택된 물질(대두의 분획물)에 용매를 첨가하고 실온에서 교반기를 이용하여 환류추출한다. 이렇게 얻어진 추출물을 여과시킨 후, 용매를 제거하고 냉동 건조하여 용매 추출물을 얻을 수 있다. 상기 용매추출물을 얻기 위해 사용되는 용매는 물, 아세톤, 에탄올, 또는 메탄올을 사용하는 것이 바람직하며, 식품에 적용하기 위해서는 물 또는 에탄올을 사용하는 것이 더욱 바람직하나, 반드시 이에 한정되지는 않는다. 또한 상기 용매는 에탄올, 아세톤, 또는 메탄올 등의 용매를 20 내지 80 %로 포함하는 것이 바람직하며, 더욱 바람직하게는 50 %의 용매를 포함하는 수용액일 수 있다. The solvent extract, as a water extract or an alcohol extract, may be prepared using conventional extraction methods well known to those skilled in the art. As an example of the preparation method of the solvent extract, a solvent is added to a substance (fraction of soybean) selected from the group consisting of soybean embryos, soybean hulls, and mixtures thereof, and the mixture is extracted under reflux using a stirrer at room temperature. After filtering the extract thus obtained, the solvent is removed and freeze-dried to obtain a solvent extract. As the solvent used to obtain the solvent extract, water, acetone, ethanol, or methanol is preferably used, and in order to apply to food, water or ethanol is more preferred, but is not necessarily limited thereto. In addition, the solvent is preferably 20 to 80% of a solvent such as ethanol, acetone, or methanol, more preferably may be an aqueous solution containing 50% of the solvent.
또한, 본 발명은 암 세포 증식 억제 효능을 갖는, 상기의 대두 배아 및/또는 대두껍질의 용매 추출물을 유효성분으로 포함하는 암 억제용 조성물을 제공한다. 본 발명의 조성물을 적용 가능한 암으로는 간암, 유방암, 위암, 또는 고형암을 포함한다.In addition, the present invention provides a composition for inhibiting cancer, comprising the solvent extract of the soybean embryo and / or soybean shell as an active ingredient, which has cancer cell proliferation inhibitory effect. Cancers to which the compositions of the present invention are applicable include liver cancer, breast cancer, gastric cancer, or solid cancer.
본 발명의 조성물은 별도의 정제 과정 없이 안전하게 섭취 가능하므로, 안정성의 확보로 식품 및 의약 조성물로서 적용시 기존의 방법보다 광범위하게 응용할 수 있다.Since the composition of the present invention can be safely ingested without a separate purification process, it can be applied more widely than conventional methods when applied as a food and pharmaceutical composition to ensure stability.
따라서, 본 발명의 조성물은 약제 조성물 또는 식품 조성물일 수 있으며, 본 발명에서 식품 조성물이라 함은 가공식품, 기능성 식품, 식이 보조제, 식품 첨가제, 기능성 음료 및 음료첨가제 등을 포함하는 것이다.Therefore, the composition of the present invention may be a pharmaceutical composition or a food composition, the food composition in the present invention includes processed foods, functional foods, dietary supplements, food additives, functional beverages and beverage additives and the like.
본 발명의 조성물에서 대두 배아 및/또는 대두 껍질의 물 또는 용매 추출물은 조성물 전체에 대하여 0.01 내지 50 중량%, 더 바람직하게는 0.01 내지 10 중량%로 포함되는 것이 바람직하다. 이때, 상기 용매 추출물의 함량이 0.01 중량% 미만이면 발암억제 효능이 미비하며, 50 중량%를 초과하면 사용량이 많아져서 경제적으로 바람직하지는 않다.In the composition of the present invention, water or solvent extracts of soybean embryos and / or soybean hulls are preferably contained in an amount of 0.01 to 50% by weight, more preferably 0.01 to 10% by weight, based on the total composition. At this time, if the content of the solvent extract is less than 0.01% by weight is insufficient carcinogenesis inhibitory effect, if it exceeds 50% by weight it is not economically preferable to increase the amount used.
또한, 본 발명의 조성물은 당업자에게 잘 알려진 약제학적으로 허용 가능한 적절한 담체, 부형제 또는 희석제를 추가로 포함하여 약제를 제조할 수 있다. 상기 담체로는 식염수, 완충 식염수, 물, 글리세롤 및 에탄올 등이 있으며, 그 밖에 적합한 담체, 부형제 및 희석제의 예로는, 락토오스, 덱스트로오스, 수크로오스, 솔비톨, 만니톨, 자이리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이 트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로오스, 메틸 셀룰로오스, 미정질 셀룰로오스, 폴리비닐피롤리돈, 물, 메틸하이드록시벤조에이트, 프로필하이드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유 등이 있다. 그러나, 본 발명이 이에 한정되지 않으며, 당해 기술 분야에 알려진 적합한 제제(Remington's Pharmaceutical Science(최근판), Mack Publishing Company, Easton PA)는 모두 사용가능하다.In addition, the compositions of the present invention may further comprise a pharmaceutically acceptable suitable carrier, excipient or diluent well known to those skilled in the art. Such carriers include saline, buffered saline, water, glycerol and ethanol, and other suitable carriers, excipients and diluents include, but are not limited to, lactose, dextrose, sucrose, sorbitol, mannitol, xyitol, erythritol, maltitol, starch, Acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methyl cellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and Mineral oil and the like. However, the present invention is not limited thereto, and any suitable agent known in the art (Remington's Pharmaceutical Science (Recent Edition), Mack Publishing Company, Easton PA) can all be used.
상기 암세포 증식 억제 효능을 갖는 대두 배아 및/또는 대두 껍질의 추출물을 유효성분으로 포함하는 조성물은 경구투여가 바람직하며, 약제로 사용할 경우 약제학적 분야에서 공지의 방법에 의하여 제조될 수 있으며, 그 형태로서는 산제, 과립제, 정제, 캅셀제, 환제, 트로키(troche), 내용액제, 현탁제, 유제, 및 시럽제 등의 경구제로 사용할 수 있다.The composition comprising the extract of soybean embryos and / or soybean hulls having the cancer cell proliferation inhibitory effect as an active ingredient is preferably orally administered, when used as a medicament can be prepared by a method known in the pharmaceutical field, the form As a powder, granules, tablets, capsules, pills, troche, liquid solution, suspension, emulsion, and syrups, or the like can be used.
본 발명에 따른 대두 배아 및/또는 대두 껍질의 용매 추출물을 포함하는 암 세포 증식 억제용 조성물을 식품으로 사용할 경우, 독성을 제거하기 위한 별도의 정제 과정 없이 안전하게 섭취함으로써 암세포 증식 억제 효능을 얻을 수 있다. 또한 간단한 분리 공정만으로 높은 암세포 증식 억제 효능을 나타내는 물질을 분리할 수 있어 종래의 암 억제제들에 비하여 생산원가를 낮출 수 있으며, 특히 대두 가공 공정중 버려지고 있는 막대한 양의 대두 껍질을 재활용함으로써 경제성을 향상시킬 수 있다.When using a composition for inhibiting cancer cell proliferation comprising a solvent extract of soybean embryos and / or soybean hulls according to the present invention as food, it is possible to obtain a cancer cell proliferation inhibitory effect by safely ingesting without a separate purification process to remove toxicity. . In addition, it is possible to separate substances that exhibit high cancer cell proliferation inhibitory effect with a simple separation process, thereby lowering the production cost compared to conventional cancer inhibitors, and in particular, by recycling the enormous amount of soybean hulls discarded during soybean processing. Can be improved.
따라서, 본 발명의 조성물을 음식물로 사용할 경우, 대두 배아, 대두 껍질 및 이들의 혼합물로 이루어진 군에서 선택된 용매 추출물을 그대로, 또는 종래 식 품에 사용되던 각종 성분과 혼합하여 식품으로 제조할 수 있다. 제조되는 음식물의 형태로서는 고형식품, 크림상, 또는 잼상의 반(半)유동식품, 겔상식품, 음료 등 온갖 식품형태로 제조할 수 있으며, 캅셀제, 과립제, 정제, 드링크제 등의 형태나, 상용되고 있는 임의의 기재를 사용하여 청량음료, 쥬스, 커피, 홍차, 리큐르, 우유, 유청음료, 유산균음료, 사탕, 츄잉검, 초콜렛, 구미, 요구르트, 아이스크림, 푸딩, 물양갱 등으로 제조할 수 있다.Therefore, when the composition of the present invention is used as a food, a solvent extract selected from the group consisting of soybean embryos, soybean hulls, and mixtures thereof may be prepared as it is, or by mixing with various components used in conventional foods. As the form of the food to be prepared, it can be prepared in all kinds of foods such as solid foods, creamy or jam-like semi-liquid foods, gel foods, beverages, etc., and are commonly used in the form of capsules, granules, tablets, drinks, etc. Any substrate can be used to prepare soft drinks, juices, coffee, tea, liqueurs, milk, whey beverages, lactic acid bacteria beverages, candies, chewing gum, chocolate, gummi, yogurt, ice cream, puddings, water yolks and the like.
이상에서 설명한 바와 같이, 본 발명의 대두 배아 및/또는 대두 껍질의 용매 추출물은 여러 암 세포 증식을 저해하는 효능을 나타냄으로써 암의 진행 단계를 저해하는 효능을 가진다.As described above, the solvent extract of soybean embryos and / or soybean hulls of the present invention has the effect of inhibiting the progression of cancer by exhibiting the effect of inhibiting the proliferation of various cancer cells.
즉, 도 1 내지 8을 통하여, 본 발명의 대두 배아 및/또는 대두 껍질의 용매 추출물은 간암, 위암, 대장암, 고형암 세포의 증식을 억제시킴으로써, 여러 암 세포의 증식을 억제 시키는 것을 알 수 있다.That is, it can be seen from FIGS. 1 to 8 that the solvent extract of the soybean embryo and / or soybean hull of the present invention inhibits the proliferation of various cancer cells by inhibiting the proliferation of liver cancer, stomach cancer, colon cancer, and solid cancer cells. .
또한 도 1 내지 8을 통하여, 암세포 증식 억제 효능을 증강시킨 대두 배아 및/또는 대두 껍질 추출물의 농도가 점차 증가할수록 여러 암 세포의 증식이 억제되는 것을 관찰함으로써, 암 세포의 증식 저해율이 처리한 대두 배아 및 대두 껍질 추출물의 농도에 의존적인 것을 알 수 있다.1 through 8, the growth of various cancer cells is inhibited as the concentration of soybean embryos and / or soybean husk extracts that enhance cancer cell proliferation inhibitory effect is gradually increased, so that the proliferation inhibition rate of cancer cells is treated. It can be seen that it depends on the concentration of the embryo and soy bark extract.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다.Hereinafter, preferred examples are provided to help understanding of the present invention, but the following examples are merely to illustrate the present invention, and the scope of the present invention is not limited to the following examples.
실시예 1 : 에탄올을 이용한 대두 추출물의 제조Example 1 Preparation of Soybean Extract Using Ethanol
대두, 배아, 반할두 껍질 각각의 대두 분획물 20 g에 50% 에탄올(Duksan, Korea) 수용액을 약 10 배정도 첨가하였고, 실온에서 교반기를 이용하여 6 시간 동안 환류추출하였다. 이렇게 얻어진 추출물을 여과지(whatmann 41)로 여과시킨 후, 40 ℃에서 2 시간 동안 용매를 제거(evaporation)시킨 후 냉동 건조하여 각각 대두, 배아, 반할두 및 대두 껍질의 용매 추출물(이하, "대두, 배아, 반할두, 껍질의 용매 추출물"이라 함)을 얻었다.About 20 times of 50% ethanol (Duksan, Korea) aqueous solution was added to 20 g of each soybean fraction of soybeans, embryos, and halved soybean hulls, and refluxed for 6 hours using a stirrer at room temperature. The extract thus obtained was filtered with filter paper (whatmann 41), followed by evaporation of the solvent at 40 ° C. for 2 hours, followed by freeze drying to obtain a solvent extract of soybean, embryo, halves, and soybean hulls (hereinafter, “soy, Embryo extract, halves, and shell extract ".
실시예 2 : 열수를 이용한 대두 추출물의 제조Example 2 Preparation of Soybean Extract Using Hot Water
대두, 배아, 반할두 껍질 각각의 대두 분획물 20 g에 80℃의 정제수를 약 10 배정도 첨가하고, 80℃에서 2시간동안 교반추출하였다. 이렇게 얻어진 추출물을 여과지(whatmann 41)로 여과하여 잔사를 제거한 후, 냉동 건조하여 각각 대두, 배아, 반할두 및 대두 껍질의 용매 추출물을 얻었다.20 g of soybean, embryo and halves of soybean hulls were added about 10-fold purified water at 80 ° C., followed by stirring extraction at 80 ° C. for 2 hours. The extract thus obtained was filtered with filter paper (whatmann 41) to remove the residue, and then freeze-dried to obtain solvent extracts of soybean, embryo, halves and soybean hulls, respectively.
실시예 3: 간암 세포의 증식 저해 효과Example 3 Inhibition of Proliferation of Liver Cancer Cells
상기 실시예에서 얻어진 대두, 배아, 반할두, 껍질의 각 용매 추출물을 이용하여 간암 세포의 증식 저해 효과를 측정하였다.The effect of inhibiting the proliferation of liver cancer cells was measured using the solvent extracts of soybeans, embryos, halves, and husks obtained in the above examples.
간암 세포주로는 SK-HEP-1을 사용하였다. 상기 암 세포주의 배양은 DMEM(Dulbeco's Modified Egles Medium)에 FBS를 10%로 첨가하고, 페니실린(penicillin) 100 IU/㎖, 스트렙토마이신(streptomycin) 100 ㎍/㎖을 첨가한 배지 를 이용하여, 5% CO2, 37℃ 배양기(Forma Scientific Co., Marjetta, OH, USA)에서 수행되었다. 세포 배양에 사용한 배지 조성물들은 모두 GIBCO BRL(Grand Island, NY, USA)사 제품을 사용하였다.SK-HEP-1 was used as a liver cancer cell line. Culture of the cancer cell line was added to DMEM (Dulbeco's Modified Egles Medium) with 10% FBS, penicillin (penicillin) 100 IU / ㎖, streptomycin (100 ㎍ / ㎖) using a medium added 5% CO 2 , 37 ° C. incubator (Forma Scientific Co., Marjetta, OH, USA). The medium compositions used for cell culture were all used by GIBCO BRL (Grand Island, NY, USA).
상기 배양한 SK-HEP-1 암 세포주를 96 웰 플레이트(well plate)에 1×104개 세포를 분주하고, 상기 실시예에서 추출한 용매 추출물을 1, 10, 25, 50, 100 mg/ml 농도로 첨가하여 72시간 동안 배양하였다.The cultured SK-HEP-1 cancer cell line was divided into 1 × 10 4 cells in a 96 well plate, and the solvent extract extracted in the above example was prepared at a concentration of 1, 10, 25, 50, 100 mg / ml. And incubated for 72 hours.
암세포의 증식 억제 정도를 측정하기 위하여, 공지의 방법(Mosmann, J. Immunol. Method, 65:55-63, 1983)에 따라 MTT 분석(assay)을 실시하였다. 배양된 세포를 인산 완충용액으로 2회 세척하였다. 96 웰 플레이트에 3-(4,5-디메틸티아졸-2-일)-2,5-디페닐테트라졸륨브로마이드(3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyl tetrazolium bromide; MTT, Sigma)를 첨가하여 37 ℃에서 4시간 동안 반응시켰다. 96 웰 플레이트를 800 g로 실온에서 25분간 원심분리하여 상층액을 제거하였다. 파란색의 포르마잔(formazan) 생성물에 디메틸설폭사이드(dimethylsulfoxide) 0.1 ㎖을 첨가하여 교반기(shaker) 위에서 80 rpm으로 30분 동안 반응시킨 후, 마이크로플레이트 리더(microplate reader, BioRad, Hercules, CA, USA)를 이용하여 570 nm에서의 흡광도를 측정하였다. 본 실시예에 따라 3회 반복 실험을 수행하였으며, 대두 추출물의 세포 증식 억제 정도를 %로 계산하여 도 1에 나타내었다.In order to measure the degree of inhibition of proliferation of cancer cells, an MTT assay was performed according to a known method (Mosmann, J. Immunol. Method , 65: 55-63, 1983). Cultured cells were washed twice with phosphate buffer. 3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyl tetrazolium in 96 well plates bromide; MTT, Sigma) was added and reacted at 37 ° C. for 4 hours. The supernatant was removed by centrifuging the 96 well plate at 800 g for 25 minutes at room temperature. 0.1 ml of dimethylsulfoxide was added to the blue formazan product and reacted at 80 rpm for 30 minutes on a shaker, followed by a microplate reader (BioRad, Hercules, CA, USA). Absorbance at 570 nm was measured using. Three repeated experiments were performed according to this example, and the degree of inhibition of cell proliferation of the soybean extract was shown in FIG. 1.
상기 결과로부터 암 세포주의 증식을 50% 억제하는 농도인 IC50 값으로 계산 한 결과, 대두, 반할두, 배아, 껍질의 에탄올 추출물의 경우 각각 36.8, 40.2, 21.1, 0.9 mg/ml 이었으며, 열수 추출물의 경우에는 각각 36.5, 27.3, 8.5, 7.0 mg/ml 이었다. From the above results, it was calculated as IC 50 value that inhibits the proliferation of cancer cell lines by 50%. The ethanol extracts of soybean, halved bean, embryo and husk were 36.8, 40.2, 21.1 and 0.9 mg / ml, respectively. In the case of 36.5, 27.3, 8.5 and 7.0 mg / ml, respectively.
상기 결과에 의하여, 4가지 대두 추출물을 비교한 결과 대두 배아 및 껍질 추출물이 간암 증식 억제 효과가 현저히 우수함을 알 수 있다.By the above results, it can be seen that the soybean embryos and bark extracts are significantly superior in inhibiting liver cancer growth as a result of comparing the four soybean extracts.
실시예 4 : 유방암 세포 증식 저해 효과Example 4: breast cancer cell proliferation inhibitory effect
상기 실시예 3와 같은 방법으로 대두 용매 추출물과 열수 추출물 각각 4가지 를 유방암 세포인 MCF 7에 여러 농도로 처리한 결과를 도 3, 4에 나타내었다. 도 3, 4에 나타낸 바와 같이, 에탄올 추출물 중에서 껍질의 IC50 값이 14.1 mg/ml로 가장 높게 나타났으며, 열수 추출물에서도 껍질의 IC50 값이 5.5 mg/ml로 가장 높았다. 상기 결과로 미루어 볼때 추출물 중에서 대두 껍질 추출물이 유방암세포 증식 저해 효능이 월등히 뛰어남을 알 수 있다.In the same manner as in Example 3, four soybean solvent extracts and hot water extracts, respectively, were treated at various concentrations in MCF 7 as breast cancer cells. As shown in Figures 3 and 4, the IC 50 value of the peel of ethanol extract was the highest as 14.1 mg / ml, the IC 50 value of the peel was also the highest as 5.5 mg / ml in hot water extract. From the above results, it can be seen that the soybean hull extract from the extract is significantly superior in inhibiting breast cancer cell proliferation.
실시예 5 : 위암 세포 증식 저해 효과Example 5 Gastric Cancer Cell Proliferation Inhibitory Effect
상기 실시예 3와 같은 방법으로 대두 용매 추출물과 열수 추출물 각각 4가지 를 위암 세포인 SNU-1에 여러 농도로 처리한 결과를 도 5, 6에 나타내었다. 도 5, 6에 나타낸 바와 같이, 대두, 반할두, 배아, 껍질의 에탄올 추출물의 경우 IC50 값이각각 34.4, 29.3, 18.5, 5.5 mg/ml 이었으며, 열수 추출물의 경우에는 각각 80.0, 49.0, 21.6, 7.3 mg/ml 이었다. 상기 결과에 의하여 처리한 대두 추출물의 농도가 점차 증가할수록 위암 세포주의 증식이 억제되는 것을 관찰하였으며, 대두 배아 및 껍질 추출물이 위암세포 증식 억제 효과가 현저히 우수함을 알 수 있다.In the same manner as in Example 3, soybean solvent extract and hot water extract, respectively, were treated at various concentrations in SNU-1, which is gastric cancer cells, and the results are shown in FIGS. 5 and 6. As shown in Figures 5 and 6, for the ethanol extracts of soybeans, halves, embryos and husks, the IC 50 values were 34.4, 29.3, 18.5 and 5.5 mg / ml, respectively, and 80.0, 49.0 and 21.6 for hydrothermal extracts, respectively. , 7.3 mg / ml. As the concentration of the soybean extract was gradually increased by the above results, it was observed that the proliferation of gastric cancer cell lines was inhibited, and that the soybean embryo and bark extract had a remarkably excellent effect of inhibiting gastric cancer cell proliferation.
실시예 6 : 고형암 세포 증식 저해 효과Example 6 Solid Cancer Cell Proliferation Inhibitory Effect
상기 실시예 3와 같은 방법으로 대두 용매 추출물과 열수 추출물 각각 4가지 를 고형암 세포인 HT1080에 여러 농도로 처리한 결과를 도 7, 8에 나타내었다. 도 7, 8에 나타낸 바와 같이, 대두, 반할두, 배아, 껍질의 에탄올 추출물의 경우 IC50 값이 각각 23.7, 26.2, 13.0, 14.1 mg/ml 이었으며, 열수 추출물의 경우에는 각각 36.8, 40.2, 21.1, 0.9 mg/ml 이었다. 상기 결과에 의하여 대두 배아 및 껍질 추출물이 고형암세포 증식 억제 효과가 현저히 우수함을 알 수 있다.In the same manner as in Example 3, soybean solvent extract and hot water extract, respectively, were treated at various concentrations in solid cancer cells HT1080, respectively, as shown in FIGS. 7 and 8. As shown in FIGS. 7 and 8, the IC 50 values were 23.7, 26.2, 13.0, and 14.1 mg / ml for the ethanol extracts of soybeans, halves, embryos, and husks, respectively, and 36.8, 40.2, and 21.1 for hydrothermal extracts, respectively. , 0.9 mg / ml. As a result, it can be seen that soybean embryos and bark extracts are remarkably excellent in inhibiting solid cancer cell proliferation.
따라서, 4가지 대두 추출물 중에서 배아 및 껍질 추출물이 간암, 유방암, 위암, 고형암 세포에 대한 증식 억제 효과가 현저히 우수함을 알 수 있다.Therefore, it can be seen that the embryo and bark extracts among the four soybean extracts are remarkably excellent in inhibiting the proliferation of liver cancer, breast cancer, gastric cancer, and solid cancer cells.
상기에서 살펴본 바와 같이, 본 발명의 대두 배아 및/또는 대두 껍질 추출물은 간암, 유방암, 위암, 고형암 세포주에 대해 현저히 우수한 증식 억제 효과를 가지며, 또한 상기 추출물은 식품 등급으로 사용할 수 있어, 독성을 제거하기 위한 별도의 정제 과정 없이 안전하게 섭취함으로써 암세포 증식 억제 효능을 얻을 수 있다. 또한, 본 발명에 따르면 간단한 분리 공정으로 발암 억제 효능을 나타내는 물질을 분리하여 제제화함으로써, 기존의 발암 억제제에 비하여 생산원가를 낮출 수 있으며, 특히 가공 과정 중 버려지고 있는 막대한 양의 대두 껍질을 재활용함으로써 경제성을 향상시킬 수 있는 장점이 있다.As discussed above, the soybean embryo and / or soybean peel extract of the present invention has a remarkably excellent proliferation inhibitory effect against liver cancer, breast cancer, gastric cancer, and solid cancer cell lines, and the extract can be used as a food grade, eliminating toxicity. It can be obtained by inhibiting cancer cell proliferation by ingesting safely without a separate purification process. In addition, according to the present invention by separating and formulating a material that exhibits carcinogenic efficacy by a simple separation process, it is possible to lower the production cost compared to the existing carcinogenic inhibitors, in particular by recycling a large amount of soybean shell discarded during processing There is an advantage to improve the economics.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040099664A KR100673594B1 (en) | 2004-12-01 | 2004-12-01 | Extracts of soy hypocotyl and/or hull with inhibitory effects on carcinogenesis and composition comprising the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040099664A KR100673594B1 (en) | 2004-12-01 | 2004-12-01 | Extracts of soy hypocotyl and/or hull with inhibitory effects on carcinogenesis and composition comprising the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060060877A KR20060060877A (en) | 2006-06-07 |
KR100673594B1 true KR100673594B1 (en) | 2007-01-24 |
Family
ID=37157506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040099664A KR100673594B1 (en) | 2004-12-01 | 2004-12-01 | Extracts of soy hypocotyl and/or hull with inhibitory effects on carcinogenesis and composition comprising the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100673594B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101240045B1 (en) * | 2005-04-15 | 2013-03-06 | 대상에프앤에프 주식회사 | A manufacturing method of soybean milk and bean-curd comprising soybean embryo |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102497827B1 (en) * | 2022-06-27 | 2023-02-08 | 주식회사 정.식품 | Lactiplantibacillus plantarum DCF49 new strain derived from shindari and production method of functional postbiotics using the same |
KR102542030B1 (en) * | 2022-12-28 | 2023-06-14 | 주식회사 정.식품 | Makgeolli-derived Lacticaseibacillus paracasei subsp. paracasei DCF0429 and functional postbiotics using the same |
-
2004
- 2004-12-01 KR KR1020040099664A patent/KR100673594B1/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101240045B1 (en) * | 2005-04-15 | 2013-03-06 | 대상에프앤에프 주식회사 | A manufacturing method of soybean milk and bean-curd comprising soybean embryo |
Also Published As
Publication number | Publication date |
---|---|
KR20060060877A (en) | 2006-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101363111B1 (en) | Pharmaceutical composition containing paddy husk and barley husk extract as activeingredient | |
KR102180223B1 (en) | Anti-obesity composition comprising extract of Sargassum horneri | |
KR100930927B1 (en) | Method for preparing caffeic acid which increases the activity of γ-UCS from perilla leaves, caffeic acid prepared therefrom, and food composition and pharmaceutical composition comprising the caffeic acid | |
KR101199961B1 (en) | Composition for Prevention or Treatment of Osteoporosis Comprising Bangpungtongseungsan and Fermentation Product Thereof with Lactic Acid Bacteria | |
KR100623972B1 (en) | Composition comprising the extract of Cinnamomum camphora Sieb. for preventing and treating inflammatory disease | |
KR101018403B1 (en) | composition comprising the extract of soybean leaves for the prevention?delay or treatment of gout | |
KR100673594B1 (en) | Extracts of soy hypocotyl and/or hull with inhibitory effects on carcinogenesis and composition comprising the same | |
US20070053929A1 (en) | Marine algae extract and lipase inhibitor containing the same | |
KR100542876B1 (en) | Composition comprising Schizandrae Fructus extract as an effective component for preventing and treating arthritis | |
KR100849678B1 (en) | Extracts of soy hypocotyl with effects on skin whitening and composition comprising the same | |
KR102014922B1 (en) | Composition for improving digestive functions comprising glabridin from Liquorice | |
KR101482044B1 (en) | Food composition comprising fermented product of Pleuropterus multiflorus and ginger for alleviating or preventing degenerative brain disorder and method of producing the same | |
KR101490794B1 (en) | Composition comprising alcohol extracts from oligoporus tephroleucus for treating or preventing hyperlipidemia | |
KR101845704B1 (en) | Composition comprising kynurenic acid for relieving hangover | |
JP2021024858A (en) | Hypotensive composition | |
KR102120323B1 (en) | Composition for hepatoprotective or ameliorating hangover containing herbal extract and edible insect enzyme-decomposed with enzyme | |
KR20150113709A (en) | Skin whitening composition containing Allium hookeri extract | |
KR20130082250A (en) | Composition for preventing or improving the hypertension containing parthenocissus tricuspidata extract | |
KR102485676B1 (en) | A composition for improving, preventing and treating of obesity comprising Ulva pertusa Kjellman extracts | |
KR101052067B1 (en) | Inflammatory disease prevention or treatment composition containing wild vegetable extract as an active ingredient | |
KR100441564B1 (en) | Extracts of buckwheat and/or buchwheat chaff with inhibitory effects on hepatocarcinogenesis and food composition comprising the same | |
KR102158661B1 (en) | Composition for preventing, ameliorating and treating inflammatory diseases comprising extract of undried immature astrigent persimmon of miyrangbansi as effective component | |
KR20120031706A (en) | Preparation method of codonopsis lanceolata extracts using ultra-high pressure | |
KR20170062017A (en) | Composition for treating or preventing cancer containing extract of cladosiphon novae-caledoniae kylin | |
KR20150122547A (en) | Composition for treating or preventing cancer containing extract of leaf of sweet potato |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130118 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140120 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150107 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160114 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170116 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180117 Year of fee payment: 12 |